HIV & COVID-19 – What do we know so far?

 

Listen to STI’s podcasts focusing on HIV & COVID-19:

COVID-19 Vaccine and People who live with HIV

Impact of HIV infection on COVID-19 clinical outcome

 

Take-home points

  • PLWHIV who have COVID-19 do as well as the general population if they have no other risk factors and who are well immune-reconstituted on anti-retroviral medication.
  • Encourage people living with HIV (PLWHIV) if admitted to hospitals to disclose their status to admitting physicians.¬†
  • Encourage admitting physicians to contact the HIV specialist team as soon as a PLWHIV are admitted.
  • Do not stop anti-retroviral medication even if the patient is very unwell without discussing it with the HIV specialist team.
  • Check for potential drug-drug interactions on www.covid19-druginteractions.org
  • Test people with COVID-19 for HIV to make sure they receive anti-retroviral medication to rescue their immune system. HIV testing saves lives!
  • PLWHIV and their community need to proactively engage with strategies to maintain their physical and mental wellbeing to avoid catching COVID-19 infection and support their immune system.

Resources

British HIV Association:

Australasian Society of HIV, viral hepatitis and STIs:

Drug-Drug Interaction check:

Reporting COVID-19 cases:

(Visited 598 times, 1 visits today)